Welgene Biotech Market Cap

Welgene Biotech has a market cap or net worth of 426.47 million as of April 29, 2026. Its market cap has decreased by -22.78% in one year.

Market Cap

426.47M

Enterprise Value

389.94M

Revenue

375.94M

Ranking

n/a

PE Ratio

320.65

Stock Price

18.15

Market Cap Chart

Since October 23, 2017, Welgene Biotech's market cap has decreased from 575.10M to 426.47M, a decrease of -25.84%. That is a compound annual growth rate of -3.45%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	426.47M	-1.61%
Dec 31, 2025	433.46M	-21.85%
Dec 30, 2024	554.64M	6.49%
Dec 29, 2023	520.85M	0.68%
Dec 30, 2022	517.35M	-9.20%
Dec 30, 2021	569.79M	-23.98%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pharmigene	504.65M
Puriblood Medical	710.08M
Sofiva Genomics	733.10M
TFBS Bioscience	737.22M
Kim Forest Enterprise	788.11M
Genetics Generation Advancement	1.16B
DIVA Laboratories	1.87B
BIONET	3.80B

Market Cap Rankings